Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. This included more than £6bn ($7.3bn) being made available by the UK Government in November 2020 for the development and procurement of successful vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccination 90

Vaccination Vaccine Production Licensing 90

Drug Discovery World

DECEMBER 6, 2023

This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% Exemptions from payment will be implemented for medicines containing a new active substance, exceptional central procurements and centrally procured vaccines. in 2024, 24% in 2025 and 26.8% in Spain and 8.25% in Ireland.

Life Science 59

Life Science Branding Medicine Pharma Companies 59

pharmaphorum

FEBRUARY 25, 2022

The past two years have shone a spotlight on the UK life sciences industry. Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. An industry that will forever play a greater role in our everyday lives. About the author.

Life Science 97

Life Science Vaccination Vaccine Pharmacy 97

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany.

Drugs 59

Drugs Life Science Gene Editing Gene 59

Delveinsight

JULY 29, 2020

Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus.

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Outsourcing services are on of the pillars of Merck’s business, delivered via its process solutions unit, part of the group’s life sciences division.

Vaccination 98

Vaccination Vaccine Manufacturing Life Science 98

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Realising the promise of cancer vaccines.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

pharmaphorum

APRIL 5, 2022

That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity. And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. Start-ups move fast and break things.

Pharma R&D 52

Pharma R&D Life Science Pharma Companies Clinical Trials 52

Drug Discovery World

MAY 22, 2023

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning are among the key areas of investment for pharma, according to a new report. Clarivate’s ‘Biopharma Dealmaking in 2023’ report examines how pharma companies are replenishing their pipelines as many face a steep patent cliff.

RNA 52

RNA Pharma Companies Antibody Life Science 52

pharmaphorum

MAY 12, 2022

People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of patient centricity. However, according to Jennifer Turcotte, pharma advisor in the company’s healthcare and life sciences division, there was also some good news.

Pharma Companies 98

Pharma Companies Life Science Compliance Branding 98

pharmaphorum

DECEMBER 16, 2020

We’ve got so many great life science assets in the UK, but there are still some gaps – manufacturing capacity being one of them.”. “We We had companies collaborating to develop laboratories. We had companies sourcing consumables for testing machines. The road to a vaccine. A collaborative future.

Vaccination 122

Vaccination Vaccine Life Science In-Vitro 122

XTalks

FEBRUARY 9, 2022

Findings from an analysis conducted by Constella Intelligence , a digital risk protection company, show widespread cybersecurity vulnerabilities that are costing pharma companies significantly. The report includes information on breaches, exposures and leaks in the pharma sphere. Pharma Cybersecurity and Cyber Attacks.

Pharma Companies 98

Pharma Companies Insulin Packaging Packaging 98

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Drug Discovery World

OCTOBER 6, 2022

Data from the BioIndustry Association (BIA) and Clarivate 4 shows 2021 was the highest year on record for investments into UK biotech and life sciences companies. In Germany the development of the Covid-19 vaccine, largely due to the achievements of BioNTech, raised the country’s biotech profile.

Development 52

Development Drugs Life Science Marketing 52

pharmaphorum

SEPTEMBER 15, 2020

For pharma companies, COVID-19 has proved that they can be agile and responsive to rapidly evolving market conditions, as evidenced by the way they have adjusted to a new global paradigm while successfully continuing operations. Preparing for an agile pharma future. Jeremy Richter, Tag. Build on the rapid responses to COVID-19.

Branding 118

Branding Marketing Pharma Companies Life Science 118

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My We looked at the areas of rare diseases, cell and gene therapy, vaccines – loads of different perspectives. Innovative offerings around market access. Smart reviewing: utilising AI and ML.

Life Science 98

Life Science Marketing Medicine Production 98

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. Supplementing pharma’s social media strategy. About the author.

Clinical Trials 96

Clinical Trials Clinical Trials Life Science Marketing 96

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.

Life Science 93

Life Science Medicine Clinical Trials Clinical Trials 93

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. There’s also that risk of a perceived coercion or influence. There’s sometimes a bit of a barrier,” he added.

Clinical Trials 91

Clinical Trials Clinical Trials Trials Clinical Research 91

The Pharma Data

NOVEMBER 20, 2020

As Pfizer and BioNTech announced news of a possible Covid-19 vaccine on November 8 , in haste, pharma leaders are rallying to ensure supply chains will be able to support distribution. Read on to find out how the pharma industry are preparing for the future. Save your early bird seat now. Download a copy of the report here.

Drugs 52

Drugs Pharma Companies Vaccination Vaccine 52

pharmaphorum

MARCH 4, 2022

When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients.

Doctors 96

Doctors Doctor Branding Pharma Companies 96

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Development 82

Development Drugs Vaccination Vaccine 82

pharmaphorum

APRIL 7, 2021

With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharma companies and will aim to keep more product rights than it did in the past. Role models.

Antibody 74

Antibody Life Science Development Regulation 74

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

XTalks

OCTOBER 4, 2023

In my current role, I have country-level responsibility for AstraZeneca’s entire portfolio, including cardiovascular, respiratory, vaccines and oncology. Considering how challenging market access can be for large, established pharma companies, what does it look like on the small biotech level?

Marketing 105

Marketing Development Drugs Gene Therapy 105

XTalks

APRIL 16, 2024

Backlash against celebrities for partnering with pharma companies isn’t new. Singer Pink also received some heat after she teamed up with Pfizer to back the company’s COVID-19 vaccine. Football star Travis Kelce was recently slammed for his partnership with Pfizer to promote the flu shot and COVID-19 booster.

Drugs 52

Drugs Pharma Companies Doctors Doctor 52

XTalks

OCTOBER 22, 2020

However, during the last months, due to COVID-19, we have observed how pharmaceutical companies have progressed very quickly through all the clinical development phases and different companies have already reached the clinical Phase III.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

DECEMBER 2, 2020

Like most pharma companies of its size, Pfizer has faced its fair share of controversy as one of the most well-known drugmakers in the world. Despite some setbacks, Pfizer remains one of the biggest pharma companies in the world today. No signs of slowing down.

Sales 128

Sales Production Drugs Marketing 128

pharmaphorum

MAY 27, 2022

There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. Underrepresentation is multifactorial, so concerted efforts from life science companies are required to address inequitable healthcare. What comes next?

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

XTalks

SEPTEMBER 5, 2023

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

Drug Discovery World

NOVEMBER 16, 2022

DDW Editor Reece Armstrong learns about Molecular Devices’ Organoid Innovation Centre (OIC) and how the company is aiming to advance research into 3D biology and organoids. . That means if two pharma companies are trying to grow say a cardiac organoid, they won’t be consistent across the board,” he says. . O’Connor says.

Drugs 97

Drugs In-Vivo In-Vitro Scientist 97

XTalks

AUGUST 24, 2021

In November 2020 during the third quarter, Berkshire spent billions of dollars on shares of four US pharma giants: AbbVie, Bristol Myers Squibb, Merck & Co. This was likely fueled by the flurry of development happening in the pharma space with COVID-19 vaccines and therapeutics. and Pfizer.

Drugs 98

Drugs Pharma Companies Vaccination Vaccine 98

Drug Discovery World

OCTOBER 4, 2022

Taking place at the ExCel in London from 4-5 October, ELRIG Drug Discovery 2022 is set to provide visitors with access to the latest trends, technologies and expertise driving the life sciences sector. . This year has seen some major deals announced by big pharma companies.

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. But Dix has also been leading the UK’s Vaccine Taskforce, after taking over the hot seat in December following the departure of Kate Bingham.

Vaccination 95

Vaccination Vaccine Life Science Antibody 95